Position in ABBV
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$46,711,681
+$7,026,281 QoQ
Shares Held
185,629
+1.7% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.76%
of 13F equity value
Holder Rank
#384
of 4,150 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ALLSTATE CORP holds $290,077,256 across 10 Drug Manufacturers - General names. ABBV ranks #3 (16.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
75,805 | $90,922,797 | |
| 2 | JNJ |
Johnson & Johnson
|
249,928 | $63,474,214 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
185,629 | $46,711,681 | |
| 4 | MRK |
Merck & Co., Inc.
|
225,796 | $29,014,786 | |
| 5 | AMGN |
Amgen Inc
|
52,252 | $18,921,494 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
107,859 | $13,626,905 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
210,034 | $12,102,159 | |
| 8 | PFE |
Pfizer Inc
|
488,127 | $11,754,098 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $46,711,681 | 185,629 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $39,685,400 | 182,470 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $30,728,477 | 134,485 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $14,865,099 | 64,201 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $658,394 | 3,547 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $12,793,291 | 61,060 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $9,329,072 | 52,499 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $322,484 | 1,633 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,004,421 | 5,856 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $1,066,377 | 5,856 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $915,252 | 5,906 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $927,451 | 6,222 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $838,290 | 6,222 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $991,600 | 6,222 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $12,771,068 | 79,024 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $10,552,127 | 78,624 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $12,042,051 | 78,624 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $22,580,626 | 139,292 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $18,859,189 | 139,285 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $4,422,022 | 40,994 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $5,025,658 | 44,617 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $5,176,920 | 47,837 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $4,704,849 | 43,909 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $3,585,496 | 40,935 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $5,073,255 | 51,673 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $3,522,416 | 46,232 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||